We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
(+5.3%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
16.14%
Top 10 Holdings %
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$112M |
| 2 |
Skyworks Solutions
SWKS
|
+$103M |
| 3 |
STMicroelectronics
STM
|
+$87.3M |
| 4 |
ASML
ASML
|
+$71.6M |
| 5 |
Palo Alto Networks
PANW
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$169M |
| 2 |
Cooper Companies
COO
|
+$103M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$102M |
| 4 |
Lam Research
LRCX
|
+$78.9M |
| 5 |
KLA
KLAC
|
+$76.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.94% |
| 2 | Technology | 31.31% |
| 3 | Financials | 8.29% |
| 4 | Industrials | 7.52% |
| 5 | Communication Services | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Manhattan Associates
MANH
$11B
| $442K | 0.01% |
+3,855
| New | +$480K |
|
|
ABGI
577
DELISTED
ABG Acquisition Corp. I
ABGI
| $436K | 0.01% |
44,498
| – | – |
|
578
PubMatic
PUBM
$624M
| $433K | 0.01% |
+27,242
| New | +$583K |
|
579
Arlo Technologies
ARLO
$1.71B
| $429K | 0.01% |
+68,409
| New | +$500K |
|
580
ManpowerGroup
MAN
$2.51B
| $429K | 0.01% |
+5,613
| New | +$491K |
|
581
TScan Therapeutics
TCRX
$48.6M
| $416K | 0.01% |
132,317
-4,613
| -3% | -$12.6K |
|
|
AXON
582
Axon Enterprise
AXON
$48.1B
| $403K | 0.01% |
+4,328
| New | +$458K |
|
|
PIPP
583
DELISTED
Pine Island Acquisition Corp.
PIPP
| $395K | 0.01% |
+40,000
| New | +$394K |
|
584
Upwork
UPWK
$1.16B
| $394K | 0.01% |
+19,045
| New | +$374K |
|
585
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $388K | 0.01% |
+15,885
| New | +$404K |
|
586
Sutro Biopharma
STRO
$429M
| $385K | 0.01% |
7,395
+3,517
| +91% | +$196K |
|
587
Caribou Biosciences
CRBU
$154M
| $374K | 0.01% |
68,802
| – | – |
|
588
Immunovant
IMVT
$8.07B
| $359K | 0.01% |
+92,100
| New | +$398K |
|
|
BAND
589
Bandwidth Inc
BAND
$1.47B
| $344K | 0.01% |
+18,265
| New | +$422K |
|
590
Trade Desk
TTD
$8.82B
| $343K | 0.01% |
+8,194
| New | +$449K |
|
591
Insperity
NSP
$1.99B
| $331K | 0.01% |
+3,312
| New | +$328K |
|
592
Unity
U
$15.4B
| $309K | ﹤0.01% |
+8,389
| New | +$476K |
|
|
APCA
593
DELISTED
AP Acquisition Corp
APCA
| $301K | ﹤0.01% |
30,000
| – | – |
|
|
IQMD
594
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
| $287K | ﹤0.01% |
28,650
+3,650
| +15% | +$36.5K |
|
|
SUMO
595
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $280K | ﹤0.01% |
+37,442
| New | +$328K |
|
596
Celestica
CLS
$42.4B
| $276K | ﹤0.01% |
+28,444
| New | +$305K |
|
597
ePlus
PLUS
$2.51B
| $271K | ﹤0.01% |
+5,094
| New | +$285K |
|
598
ADC Therapeutics
ADCT
$137M
| $269K | ﹤0.01% |
+33,841
| New | +$320K |
|
599
Fabrinet
FN
$19.1B
| $256K | ﹤0.01% |
+3,154
| New | +$284K |
|
600
Tevogen Inc. Common Stock
TVGN
$28.6M
| $250K | ﹤0.01% |
500
| – | – |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.
- Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
- Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
- Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
- Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
- Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
- Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
- Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.
Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.